Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Clinical Trial Quality: “Good Enough” Isn’t Good Enough For Patients

Settling for “good enough” undermines clinical trial quality in drug development and risks trial failure and regulatory rejection. Here’s what pursuing greatness actually requires.

Clinical Trial Quality: “Good Enough” Isn’t Good Enough For Patients

We haven't written up this one. Forbes has the full story — the link below goes straight to it.

Read the original at forbes.com →

More in Health & Medicine

More from Friday 2 October →